Aytu Biopharma (AYTU) EBITDA (2010 - 2026)
Aytu Biopharma's EBITDA was $344,000 in fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$6.16 million a year earlier.
Powered by 
Analysis
Aytu Biopharma (AYTU) EBITDA (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), EBITDA at Aytu Biopharma came in at -$4.39 million.
- In earlier fiscal years, EBITDA was -$2.45 million in FY2025, $5.13 million in FY2024, -$8.25 million in FY2023 and -$99.76 million in FY2022.
- The fiscal Q4 2026 figure marks the highest quarterly EBITDA since fiscal Q3 2025.
- Per Business Quant data, AYTU's EBITDA in the three fiscal quarters before Q4 2026 was -$2.94 million (Q3 2026), -$1.09 million (Q2 2026) and -$701,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Aytu Biopharma | 23.58 Mn | -92.10 Mn | 10.41 Mn | 344,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 344,000.00 |
| Mar 31, 2026 | -2.94 Mn |
| Dec 31, 2025 | -1.09 Mn |
| Sep 30, 2025 | -701,000.00 |
| Jun 30, 2025 | -6.16 Mn |
| Mar 31, 2025 | 3.71 Mn |
| Dec 31, 2024 | -403,000.00 |
| Sep 30, 2024 | 404,000.00 |
| Jun 30, 2024 | -715,000.00 |
| Mar 31, 2024 | -64,000.00 |
| Dec 31, 2023 | 4.55 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | -6.37 Mn |
| Dec 31, 2022 | -4.66 Mn |
| Sep 30, 2022 | 493,000.00 |
| Jun 30, 2022 | -14.72 Mn |
| Mar 31, 2022 | -50.85 Mn |
| Dec 31, 2021 | -8.62 Mn |
| Sep 30, 2021 | -25.02 Mn |
API Access
Aytu Biopharma EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();